Scientific Sunday Series

Migraine...

---

Title: Treatment of Migraine With Pulsing Electromagnetic Fields: A Double-Blind, Placebo-Controlled Study

Location in PEMF Global Library: Migraines folder
Published: December 1985

Applied Frequencies: 260 Hz
Available in: iMRS Prime Trial
 
Abstract: A pulsed magnetic field (f = 260 Hz; t = 3 ms; induction B = 1.9 mT; gradient = 0.5mT/cm) was applied at 40 patients with headaches of various etiology. The change of cephalea intensity was evaluated according the patients statements. These statements were further compared with the changes of the EEG.
 
Conclusion: The retreat of subjective difficulties as well as the amelioration of EEG were stated accordingly at headaches, which were bounded with cerebral arteriosclerosis, with states after cerebral concussion, with depressive neurosis, or with tension headache.

Title: Effect of adjunctive intermittent theta‑burst repetitive transcranial magnetic stimulation as a prophylactic treatment in migraine patients: A double‑blind sham‑controlled study

Location in PEMF Global Library: Migraines folder
Published: 2019
​
Applied Frequencies: 1 Hz, 5 Hz
Available in: Omnium1, iMRS Prime Trial
 
Abstract: This study was designed to assess the efficacy of adjunctive intermittent theta‑burst stimulation (iTBS) to the left dorsolateral prefrontal cortex (DLPFC), as a prophylactic treatment in migraine.
 
Conclusion: Compared to sham stimulation, adjunctive active iTBS over the left DLPFC was safe and effective in reducing the frequency, duration, and severity of migraine headache and in reducing disability associated with the illness.

---

Title: The efficiency of pulsed electromagnetic field in refractory migraine headaches: a randomized, single-blinded, placebo-controlled, parallel group

Location in PEMF Global Library: Migraines folder
Published: February 2016

Applied Frequencies: 10 Hz
Available in: Omnium1, iMRS Prime Trial
                                             
Abstract: The study attempts to investigate the effect of PEMF therapy on Refractory Migraines (RM), both those which were related and those which were not related to menstrual cycle, in a randomized, single blind, placebo-controlled study.
 
Conclusion: PEMF (10 Hz, 4-5 mT) can be considered as a beneficial and persistent prophylactic treatment option for refractory migraine.

---

Want complete access to the library?  

Simply purchase an Omnium1 2.0 or iMRS through PEMF Global.  Call 1-833-879-7363 for more information.